Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
ImmunoMet Appoints Briggs W. Morrison, M.D., and Paul Lammers, M.D., M.Sc., to Board of Directors 2017-11-28 21:00
New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal 2017-11-22 22:30
Shineco, Inc. Enters into RMB 1.12 Billion Worth of Strategic Cooperation Agreement for Apocynum Industrial Park Projects in the Nationally Designated Economic Development Zone in Xinjiang, China 2017-11-21 22:00
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017 2017-11-21 05:01
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017 2017-11-16 05:30
Yew Bio-Pharm Group Reports 2017 Third Quarter Financial Results 2017-11-14 05:05
China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 2017-11-02 04:30
TWi Biotechnology Inc. Presents Positive Results from AC-201 CR Phase 2 Proof-of-Concept Study in Gout Patients in 2017 ACR/ARPH Annual Meeting 2017-11-01 17:05
Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation 2017-10-26 00:07
China Biologic Products to Report Third Quarter of 2017 Financial Results 2017-10-25 20:00
China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition 2017-10-13 20:00
China Biologic Agrees to Acquire TianXinFu from PWM 2017-10-12 20:30
China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen 2017-10-09 20:30
Foresee Pharmaceuticals and TRPharm Announce License and Distribution Agreement 2017-09-27 19:56
VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits 2017-09-22 20:30
$5.8 Million Awarded For Vaccine Engineering Will Use "Immune History" To Protect Against Bird Flu, A Collaboration Led By EpiVax 2017-09-18 23:29
Yisheng Biopharma Announces New Breakthrough Results on YS-ON-001 in Multiple Solid Tumor Experiments 2017-08-30 20:00
Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice 2017-08-29 04:00
Lumosa Therapeutics Partners with Camargo Pharmaceutical Services in the Development of Naldebain(R) in the US 2017-08-28 14:09
CARsgen Launches First-in-Class Anti-Claudin18.2 CAR-T Clinical Trial 2017-08-10 14:10
1 143 144 145 146 147 165